Li Jingjing, Zhang Lihong, Zhang Chunfang, Cheng Jye Yuan, Li Jinrang, Jeff Cheng Chieh-Fu
Department of Otolaryngology, Peking University People's Hospital, Beijing, China.
Department of Otolaryngology, Peking University People's Hospital, Beijing, China.
J Voice. 2016 Jan;30(1):104-8. doi: 10.1016/j.jvoice.2013.12.006. Epub 2015 Aug 17.
Currently, there is no cost-effective tool available to diagnose laryngopharyngeal reflux (LPR) in the developing country of China. The aim of this study was to achieve a linguistic adaptation of the Chinese version of the Reflux Symptom Index (RSI-CH).
A nonrandomized, controlled, prospective trial.
A total of 107 patients at the outpatient clinic of Peking University People's Hospital were enrolled. They were asked to fill out the RSI-CH and underwent fiber-optic laryngoscopy to complete the Reflux Finding Score (RFS). Patients underwent pH monitoring if the RSI-CH was greater than 13 or if the RFS was not less than 7. Patients were treated with Omeprazole 20 mg twice a day for 3 months if the pH monitoring was positive. The reliability (Cronbach alpha coefficient and Spearman correlation analysis), validity (sensitivity, specificity, and positive and negative predictive values), and responsivity of RSI-CH were determined.
RSI-CH had a good reliability (Cronbach alpha coefficient was greater than .7, whereas the test-retest validity for the total score and for each item were 0.750-0.971. The scale had a good criterion validity. The consistency (66.7%), sensitivity (61.76%), and specificity (75%), and the positive and negative predictive values (80.8% and 53.6%) were considered good. The RSI-CH scores changed from 15 to 7 after treatment, and the average score of the controlled group was 6.5.
The RSI-CH developed and validated by this study can be used as an effective diagnostic tool in identifying differentiating LPR diseases in patients whose native language is Chinese.
目前,在中国这个发展中国家,尚无经济有效的工具可用于诊断喉咽反流(LPR)。本研究的目的是对反流症状指数中文版(RSI-CH)进行语言适应性调整。
一项非随机、对照、前瞻性试验。
北京大学人民医院门诊共纳入107例患者。他们被要求填写RSI-CH,并接受纤维喉镜检查以完成反流发现评分(RFS)。如果RSI-CH大于13或RFS不小于7,则患者接受pH监测。如果pH监测呈阳性,患者接受奥美拉唑20mg每日两次治疗3个月。确定RSI-CH的可靠性(Cronbachα系数和Spearman相关性分析)、有效性(敏感性、特异性以及阳性和阴性预测值)和反应性。
RSI-CH具有良好的可靠性(Cronbachα系数大于0.7,总分及各项目的重测效度为0.750 - 0.971)。该量表具有良好的效标效度。一致性(66.7%)、敏感性(61.76%)和特异性(75%)以及阳性和阴性预测值(80.8%和53.6%)被认为良好。治疗后RSI-CH评分从15降至7,对照组平均评分为6.5。
本研究开发并验证的RSI-CH可作为一种有效的诊断工具,用于识别以中文为母语的患者中的LPR疾病并进行鉴别诊断。